PO-1181: Metastasis-Directed Therapy influence in clinical outcomes of oligorrecurrent prostate cancer. (November 2020) - Gonzalez Lopez, A.; Büchser, D.; Suarez, F.; Mayrata, E.; Casquero, F.; Bilbao, P.; Gomez-Iturriaga, A.